Skip to Main content Skip to Navigation
Journal articles

Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Abstract : BACKGROUND: Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect. In order to determine the cause of our failure to detect a second mutation by sequencing in patients with mild HPP and carrying on a single heterozygous mutation, we tested the possible dominant effect of 35 mutations carried by these patients. METHODS: We tested the mutations by site-directed mutagenesis. We also genotyped 8 exonic and intronic ALPL gene polymorphisms in the patients and in a control group in order to detect the possible existence of a recurrent intronic mild mutation. RESULTS: We found that most of the tested mutations exhibit a dominant negative effect that may account for the mild HPP phenotype, and that for at least some of the patients, a second mutation in linkage disequilibrium with a particular haplotype could not be ruled out. CONCLUSION: Mild HPP results in part from compound heterozygosity for severe and moderate mutations, but also in a large part from heterozygous mutations with a dominant negative effect.
Complete list of metadata

Cited literature [26 references]  Display  Hide  Download

https://hal-unilim.archives-ouvertes.fr/hal-00622896
Contributor : Franck Sturtz <>
Submitted on : Tuesday, September 13, 2011 - 8:49:27 AM
Last modification on : Friday, December 11, 2020 - 3:09:42 AM
Long-term archiving on: : Wednesday, December 14, 2011 - 2:21:17 AM

File

1471-2350-10-51.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Delphine Fauvert, Isabelle Brun-Heath, Anne-Sophie Lia-Baldini, Linda Bellazi, Agnès Taillandier, et al.. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.. BMC Medical Genetics, BioMed Central, 2009, 10, pp.51. ⟨10.1186/1471-2350-10-51⟩. ⟨hal-00622896⟩

Share

Metrics

Record views

494

Files downloads

902